F-STAR THERAPEUTICS INC (FSTX) Stock Analyst Earnings Estimates
NASDAQ:FSTX - Nasdaq - US30315R1077 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 11.26M | 21.167M 87.98% | 4.093M -80.66% | 1.275M -68.85% | 3.4M 166.67% | 2.733M -19.62% | 24.78M 806.70% | 47.121M 90.16% | 128.32M 172.32% | 314.52M 145.11% | 576.39M 83.26% | ||
| EBITDA YoY % growth | -32.66M -15.90% | -21.25M 34.94% | -30.072M -41.52% | -53.754M -78.75% | -62.322M -15.94% | -75.582M -21.28% | -84.15M -11.34% | -78.132M 7.15% | -68.646M 12.14% | N/A | N/A | N/A | |
| EBIT YoY % growth | -33.02M -15.98% | -22.39M 32.19% | -30.714M -37.18% | -56.986M -85.54% | -68.43M -20.08% | -79.069M -15.55% | -87.95M -11.23% | -80.542M 8.42% | -66.819M 17.04% | 41.086M 161.49% | 159.58M 288.40% | 382.26M 139.54% | |
| Operating Margin | N/A | -198.85% | -145.10% | -1,392.29% | -5,367.06% | -2,325.56% | -3,218.07% | -325.03% | -141.80% | 32.02% | 50.74% | 66.32% | |
| EPS YoY % growth | -5.88 7.55% | -6.54 -11.22% | -2.01 69.27% | -2.81 -39.55% | -3.05 -8.82% | -2.81 7.99% | -2.49 11.20% | -1.38 44.79% | -1.43 -3.70% | 1.11 177.86% | 4.27 284.40% | 10.18 138.19% |
All data in USD
| Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.56 -217.41% | -0.78 -36.00% | -0.80 9.59% | -0.71 15.00% | -0.73 -30.32% | -0.78 | -0.87 -8.97% | -0.91 -27.14% | -0.95 -29.17% |
| Revenue Q2Q % growth | -100.00% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -15.09M -449.06% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -0.84 -61.54% | -0.80 | -0.04 | -4.58% |
| Q2 2022 Q2Q % growth | -0.88 1.12% | -0.60 | -0.28 | -47.48% |
| Q1 2022 Q2Q % growth | -0.57 47.22% | -0.69 | 0.12 | 17.12% |
| Q4 2021 Q2Q % growth | 0.48 122.86% | -0.12 | 0.60 | 516.97% |
| Q3 2021 Q2Q % growth | -0.52 58.06% | -0.60 | 0.08 | 12.75% |
| Q2 2021 Q2Q % growth | -0.89 28.23% | -0.76 | -0.13 | -17.46% |
| Q1 2021 Q2Q % growth | -1.08 44.90% | -1.19 | 0.11 | 9.04% |
| Q4 2020 Q2Q % growth | -2.10 -16.67% | -0.66 | -1.44 | -220.03% |
| Q3 2020 Q2Q % growth | -1.24 26.19% | -1.02 | -0.22 | -21.57% |
| Q2 2020 Q2Q % growth | -1.24 -10.71% | -1.47 | 0.23 | 15.58% |
| Q1 2020 Q2Q % growth | -1.96 -53.12% | -0.82 | -1.14 | -140.20% |
| Q4 2019 Q2Q % growth | -1.80 | -2.73 | 0.93 | 34.15% |
| Q3 2019 Q2Q % growth | -1.68 | -2.48 | 0.80 | 32.22% |
| Q2 2019 Q2Q % growth | -1.12 | -2.26 | 1.14 | 50.54% |
| Q1 2019 Q2Q % growth | -1.28 | -2.13 | 0.85 | 39.90% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | 1.125M 49.80% | 30.6K | 1.094M | 3,576.47% |
| Q2 2022 Q2Q % growth | -100.00% | 1.766M | -1.766M | -100.00% |
| Q1 2022 Q2Q % growth | 2.551M -12.64% | 1.326M | 1.225M | 92.38% |
| Q4 2021 Q2Q % growth | 17.499M 55.41% | 10.176M | 7.323M | 71.96% |
| Q3 2021 Q2Q % growth | 751K | 2.527M | -1.776M | -70.28% |
| Q2 2021 Q2Q % growth | 2.917M | 766.316K | 2.151M | 280.65% |
| Q1 2021 Q2Q % growth | 2.92M | 1.224M | 1.696M | 138.56% |
| Q4 2020 Q2Q % growth | 11.26M | 703.8K | 10.556M | 1,499.89% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | 0.15% | 0.15% |